|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3525 USD | -6.25% |
|
-12.96% | -70.00% |
| 05-27 | Kaos Capital acquires 4.9% stake in BioRestorative Therapies | RE |
| 05-26 | BioRestorative Completes Dosing in Phase 2 Trial of BRTX-100 to Treat Chronic Lumbar Disc Disease; Shares Rise | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 0.479 | 1.22 | 0.5947 |
| Spread/Res. | -26.41% | -71.11% | -40.73% |
| Spread/Supp. | +33.67% | +107.60% | +83.40% |
| Support | 0.2637 | 0.1698 | 0.1922 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BRTX Stock
- Charts BioRestorative Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
